The Bio-Hermes research study seeks volunteers with or without memory concerns to help identify blood or digital tests that could help predict the presence of amyloid plaques in the brain.

The Apheleia research study seeks volunteers with memory or cognitive issues to help identify early markers for Alzheimer’s disease by using cognitive tests and a blood draw.

Ready to take the first step in your clinical research journey?

Join the Apheleia study and see how you might match into an Alzheimer’s disease clinical trial.

Why are pre-screeners needed?

Alzheimer’s clinical trials can be complex and expensive, making the trial last longer and challenging to recruit and retain volunteers.

Pre-screeners seek to identify early markers of the disease to help predict if a person has Alzheimer’s and, if they would like to, enroll them in an appropriate clinical trial. The Apheleia study will expediate research by simplifying the screening process for Alzheimer’s studies.

Apheleia will use demographic information such as gender, age, race and ethnicity, medical history, cognitive tests, and a blood draw to help identify people who may have markers, or biological signs of Alzheimer’s disease.

Who can participate?

The Apheleia study is seeking approximately 2,000 volunteers of all races, ethnicities, and background who:

  • Are 50 to 90 years old
  • Are experiencing trouble with their memory or thinking
  • Have someone who can participate with you as a study partner
    • A Study partner is a trusted family member or friend who will accompany you to each of your visits and appointments involving the study. They will not have to answer any questions regarding their health or undergo any procedures.

What does the study involve?

The Apheleia study will require one (1) visit to the research center and one (1) follow-up phone call. No experimental treatments or medications are part of this study.

What are the benefits of participating in this study?

The Apheleia study will introduce you to Alzheimer’s research and clinical trials. Other benefits are:

  • You can be part of the research team trying to find therapies and treatment for Alzheimer’s disease
  • You may help represent individuals of a similar background, race, and ethnicity through participation
  • The information learned may help future generations and further research
  • Participation is at no financial cost to you

If you are interested in participating in the Apheleia research study for Alzheimer’s disease, please contact the study team for information.